The BD Stent is designed for treatment of benign oesophageal strictures (peptic, anastomotic, caustic) and achalasia resistant to standard therapy.

Features and benefits

  • Pull –back delivery system / Splittable olive tip / Automatic detachment while stent starts delivery /  Prevention of olive entrapment / Easy insertion and safe removal of delivery system
  • Radiopaque markers / Accurate stent positioning
  • Anti-migration design / Dual flared design / Reduced migration rates
  • Integrity and radial force of stent is maintained for 6-8 weeks following implantation / Extended period of dilation compared to conventional methods
  • Disintegration of stent usually occurs after 11-12 weeks following implantation / No need for removal
  • Simple compression procedure / Compression tool available

Stent sfter deployment                    4 weeks after immplantation


BD Stent - Loading procedure (ver 3)

Get Adobe Flash playerThis object requires Flash and Javascript installed and enabled


BD Stent - Loading procedure (ver 4 - for diameter 23/18/23)

Get Adobe Flash playerThis object requires Flash and Javascript installed and enabled


ELLA CS has a full range of stents suitable for indications along the full GI tract, for more information contact us here.


Reference Material


Griffiths EA, Gregory CJ, Pursnani KG, Ward JB, Stockwell RC.  The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease.  Surg Endosc 2012 Aug; 26(8): 2367-75.

… 25 attempts at placing SX-ELLA biodegradable oesophageal stents were made … BD SX-ELLA oesophageal stents work well for the duration of their life span and result in significant improvements in dysphagia scores …

van Boeckel PG, Vleggaar FP, Siersema PD.  A comparison of temporary self-expanding plastic and biodegradable stents for refractory benign esophageal strictures.  Clin Gastroenterol Hepatol 2011 Aug; 9(8): 653-9.

... Placement of self expandable plastic stents (SEPSs) or biodegradable stents provides long-term relief of dysphagia in 30% and 33%, respectively, of patients with refractory benign esophageal stricture.  Biodegradable stents require fewer procedures than SEPSs …

van Hooft JE, van Berge Henegouwen MI, Rauws EA, Bergman JJ, Busch OR, Fockens P.  Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent.  Gastrointest Endosc 2011 May; 73(5): 1043-7

… conventional techniques are typically executed on an interval basis requiring multiple endoscopic procedures, the biodegradable stent causes a gradual dilation during several weeks … SX-ELLA biodegradable esophageal stent in patients with dysphagia caused by benign anastomotic esophageal strictures has promise in regard to efficacy and safety …

Gastroenterological Endoscopy, Second Edition, Thieme, 2010 Meinhard Classen, Guido N J Tytgat, Charles J Lightdale On page 396 you can find the description of degradable stents.

“Biodegradable stents have the potential to allow treatment of benign disease without the need for additional procedures to remove them.  One such stent is the SX-ELLA (ELLA-CS, Hradec Králové, Czech Republic), designed for the treatment of benign strictures and of achalasia refractory to other therapies.”­

This article does not mention clinical efficiency and safety of the BD stent.  However there are already numerous publications giving this evidence.